A leading healthcare technology company, which leverages next-generation technologies to support and engage patients in chronic disease management, chose Genpact to develop the Diabetes Manager Platform. With a 75% user-acceptance rate, this modular disease-management platform is the first mobile prescription therapy of its kind cleared by the FDA for adults with Type 2 Diabetes. The application, which include a personalized virtual coach, enables patients to access their medical records anytime, anywhere. The app not only improved patient health outcomes but also boosted patient loyalty, with 92% repeat visitors every week.
Managing chronic diseases requires regular monitoring, frequent doctor visits, and ongoing medication adjustments, all of which underscore the need for constant connection between patients and care providers. An increasing number of patients are now interested in self-managing their health and wellness. Yet, self-diagnosis and treatment based on unverified online information can often be dangerous. In conditions like diabetes, patients need a user-friendly platform to learn more about their condition and to proactively manage it, while physicians need the ability to monitor patients vitals and prescribe or adjust treatment immediately. While mobile-based applications and health-monitoring devices have proliferated in recent years, few succeed in securing long-term user-adoption, providing accurate and timely insights to patients and their caregivers, and driving behavioral changes that lead to superior patient health outcomes.
A Lean DigitalSM approach that leveraged design thinking and advanced digital technologies to help create an innovative solution that addressed the key outcomes – empower physicians with uninterrupted access to patient data, and give them the ability to provide coaching and feedback to patients in real time to support health and drive patient adoption and loyalty.
The solution improves the delivery of care by enabling patients to better understand their own illness. Patients input personal health information, such as medication, diet, exercise, and glucose levels, using a mobile phone; they then receive immediate, real-time feedback from physicians and case managers via the mobile app, which is personalized to the specific needs of their condition. Also, instead of waiting for an health emergency to occur, the platform scans the continuous input of information and performs pattern-matching to predict and prevent such events. For instance, if a patient has been taking the maximum dose of efficacious oral medications, yet is unable to control their sugar level, the system suggests the patient begin taking insulin. The system utilizes OpenNMS based proprietary algorithms, which dynamically update patient data, and then leverage it to perform pattern-matching.
More than 50 different rules, working in cohesion, were formulated to bring this solution to life. The system can monitor patient health over a period of time, suggest medication changes, and even spot discrepancies in care and treatment plans. Doctors access this data to monitor and communicate with their patients. Thus, this engages patients in positive behavioral change and helps doctors provide real-time treatment recommendations apart from office visits. In this way, the feedback-to-behavior-change cycle is substantially improved.
Some highlights of the solution include:
- Enterprise mobile strategy/assessment
- HIPAA and FDA compliant design—the first mobile prescription therapy of its kind cleared by the FDA
- Human factors study to cater to the specific needs of a diverse demographic user set, facilitating user-friendly experiences
- Connected solution with AllScript and SureScript for electronic health records and clinical decision support systems
- Offline clinical coach and algorithms
- HL7-based integration interface
- Collaboration with a leading automobile manufacturer for in-car personalized cloud-based solution to provide patients with asthma and diabetes real-time patient coaching, behavioral education and medication adherence support
- Made for iPhone (MFI) compliant hardware connection for glucometer via Bluetooth
The application impacts the coordination of care on many levels, but the critical areas of importance are illustrated in Figure 1.
The solution resulted in the following outcomes:
- Dramatically improved feedback-to-behavior-change cycle
- 1.9% drop in blood glucose (A1C) levels among patients using the application
- Wide user-acceptance with 75% of invited patients signing up for the Diabetes Manager App (5,000+ deployments), strengthening the client’s brand image
- Increased patient loyalty with 92% of users engaging with the application several times per week
- 501(k) clearance from the FDA for the app, meaning it is approved for use as a viable alternative for treating diabetes